(Date:11/20/2008)...wswire/ Bayer HealthCare,has donated hundreds of ...y,(CFBNJ) in response to an urgent call from Gove...es to help restock supplies at the state,s food ba...bin/prnh/20081120/NETH138 ) , Mary Lou Panzano...ing,manager, Field Communications, welcomed Samu...
(Date:11/20/2008)...vestor group in Trinity,Biotech plc (Nasdaq: TR...,diagnostic products whose shares are traded in t..., is encouraged that Clint Severson has joined the...g on the news, Tom Reidy stated, "We are delighted... director, bringing the total of independent,dire...
(Date:11/20/2008)...s were infected last year , , THURSDAY, ...ealth officials recommended routine HIV testing fo...-miss, and the AIDS epidemic marches on. , This...sting methods, according to participants at a conf... designed to review the state of the AIDS epidemic...
(Date:11/20/2008)...o lower your risk for type,2 diabetes and heart d...ivity,three times a day. Ten times three -- it,s ...s for Disease Control and Prevention recommend to ...holesterol and lose weight. , In the United...nd heart,disease is the leading cause of death. B...
Breaking Medicine News(10 mins):Health News:Bayer HealthCare Donates Hundreds of Food Items to Community Food Bank of New Jersey in Response to Governor's Plea to Help the State's Population in Need 2Health News:Investor Group Commends Clint Severson for Joining Trinity Biotech's Board of Directors 2Health News:U.S. Lags on HIV Testing Goals 2Health News:U.S. Lags on HIV Testing Goals 3Health News:10 Minutes at a Time: Simple Steps to Get Moving and Reduce Your Risk of Diabetes and Heart Disease 2(Date:11/20/2008)...ewswire/ -- Clinical data from a prospective,regi...Symposium shows DVT,treatment with the Trellis(R)..., Inc. (Santa Clara, CA) successfully breaks up th.... , This technique, called isolated pharmac...e quickly and safely than current catheter-directe...
(Date:11/19/2008)...not achieve statistical significance , , IS...rmos Corporation (Nasdaq: PARS ) today announced...opical NanoEmulsion (NE) drug delivery technology ... , The multi-center, randomized, double-blinde...nd efficacy of the Company,s 3% Diclofenac Diethan...
(Date:11/18/2008)...RNewswire-FirstCall/ -- NeuroDiscovery Ltd (ASX:,...d drug development Company,and Sosei Group Corpo...ng,international biopharmaceutical company, today...er pivotal pre-clinical efficacy data for NSL-043/...herapy for neuropathic pain and has,successfully ...
(Date:11/18/2008)...enroll newly diagnosed, elderly AML patients , ...ator Pharmaceuticals today announced that the firs... clinical study of CPX-351 (Cytarabine:Daunorubici...osed acute myeloid leukemia (AML). , , The ...the Weill Medical College of Cornell University ...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3Cytochroma Appoints R Richard Wieland II As CFO 5293 1Cytochroma Appoints R Richard Wieland II As CFO 5293 2Medifast Announces First Quarter 2008 Financial Results 18997 1Medifast Announces First Quarter 2008 Financial Results 18997 2Medifast Announces First Quarter 2008 Financial Results 18997 3Medifast Announces First Quarter 2008 Financial Results 18997 4Medifast Announces First Quarter 2008 Financial Results 18997 5Medifast Announces First Quarter 2008 Financial Results 18997 6Medifast Announces First Quarter 2008 Financial Results 18997 7Medifast Announces First Quarter 2008 Financial Results 18997 8Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE 28TM 29 Brand Heparin Coated Thoracic Drainage Catheters Used for Autotransfusion During 18992 1Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE 28TM 29 Brand Heparin Coated Thoracic Drainage Catheters Used for Autotransfusion During 18992 2Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 1Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 2Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 3Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 4Newsweek International Editions 3A Highlights And Exclusives May 19 2008 5290 5...w Dissociation from HCV,Protease , ,WASHINGTON, Ma...etwork/ -- InterMune, Inc. (Nasdaq: ITMN) today pr...titis C virus (HCV) NS3/4A,protease inhibitor, ITM...e Disease Week (DDW) meeting being held May 19-24 ...ct #M1816) examined,ITMN-191 potency and binding k...
... FDA for long-term maintenance,treatment of COPD b...ed formoterol fumarate provides improved lung func... patient quality of,life, and positive safety prof... Data presented at the,International Conference of...hat Perforomist (formoterol fumarate) Inhalation,S...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 4InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: